Not applicableUnknownNCT01685918What this trial is testingSafety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hanyang University 600
Not applicableWithdrawnNCT04321603What this trial is testingAltering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65Who this might be right forHivFrailty Syndrome University of Maryland, Baltimore
Not applicableStudy completedNCT04589910What this trial is testingMeasuring Thickness of the Normal Diaphragm in Children Via Ultrasound.Who this might be right forMechanical Ventilation ComplicationPediatric ALLIntensive Care Unit Acquired Weakness Erasmus Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT01523860What this trial is testingBrief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular LymphomaWho this might be right forFollicular Lymphoma Fondazione Italiana Linfomi - ETS 76
Testing effectiveness (Phase 2)Study completedNCT00690560What this trial is testingCombination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell LymphomaWho this might be right forLymphoma Centre Antoine Lacassagne 30
Testing effectiveness (Phase 2)Study completedNCT01087424What this trial is testingMini-CHOP and Rituximab in Patients Aged Over 80 YearsWho this might be right forDiffuse Large B-Cell Lymphoma Lymphoma Study Association 150
Testing effectiveness (Phase 2)Study completedNCT03567876What this trial is testingRituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCLWho this might be right forLymphoma, Mantle-Cell Fondazione Italiana Linfomi - ETS 141
Not applicableLooking for participantsNCT07684131What this trial is testingEWALL-PH OBSERVARTORY 2022Who this might be right forAcute Lymphoblastic Leukemia Versailles Hospital 100
Not applicableStudy completedNCT05769101What this trial is testingEffects of a Recovery Supplement on Body Composition, Performance, Muscular Properties, and WellbeingWho this might be right forProtein DeficiencyTraining Group, SensitivityFatigue+2 more Joel Puente 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06272409What this trial is testingEfficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.Who this might be right forAllergic Rhinitis EMS 318
Testing effectiveness (Phase 2)UnknownNCT04928963What this trial is testingFighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly.Who this might be right forFrailtyInflammationImmune System Disorder University of Genova 40
Not applicableStudy completedNCT03746392What this trial is testingProject to Improve Communication About Serious Illness - Pilot StudyWho this might be right forMalignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more University of Washington 150
Not applicableUnknownNCT03974555What this trial is testingEpidemiological Investigation and Cohort Study on Food Allergy in Children Aged 3 to 6 Years in Wenzhou and Taizhou Urban AreasWho this might be right forFood Hypersensitivity Second Affiliated Hospital of Wenzhou Medical University 8,000
Early research (Phase 1)Ended earlyNCT01551043What this trial is testingAllo CART-19 ProtocolWho this might be right forAcute Lymphocytic Leukemia University of Pennsylvania 2
Not applicableActive Not RecruitingNCT06566885What this trial is testingReal-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in RussiaWho this might be right forSevere Asthma AstraZeneca 125
Testing effectiveness (Phase 2)Study completedNCT00003230What this trial is testingPaclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaWho this might be right forLeukemia Swiss Cancer Institute 33
Testing effectiveness (Phase 2)Looking for participantsNCT05039619What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsWho this might be right forLupus Nephritis Hoffmann-La Roche 40
Not applicableStudy completedNCT06513520What this trial is testingEvaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric ServiceWho this might be right forImmune System Hospices Civils de Lyon 81
Not applicableStudy completedNCT04052126What this trial is testingAn Individualized Physical Activity Program in Patients Over 65 Years With Hematologic MalignanciesWho this might be right forAgedAged, 80 and OverLeukemia, Myeloid, Acute+4 more Centre Leon Berard 43
Not applicableStudy completedNCT03854123What this trial is testingMultiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI CharacteristicsWho this might be right forMultiple Sclerosis University Hospital, Bordeaux 159